The SMARCA4 gene helps control which other genes are switched on or off, guiding normal growth, development, and cell repair. The protein made by this gene helps your cells organize DNA so important instructions are read at the right time. If the SMARCA4 gene does not work properly, some people can have developmental differences such as Coffin-Siris syndrome, while others may have a higher chance of certain cancers, including some ovarian, lung, and rare chest tumors.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to produce proteins, the cell components that do the work. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. As a whole, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To explore this subject in more detail, you can learn more in LearnHub.
Overview
SMARCA4Gene function
What if the gene works
The SMARCA4 gene helps cells unpack DNA so the right genes turn on and off at the right time. This supports normal growth, development, and DNA repair.
Risk
What if the gene does not work
More severe variants in the SMARCA4 gene can cause childhood cancer risk, especially rhabdoid tumors. Other variants may cause Coffin-Siris syndrome, a condition affecting development and learning. Features can vary in type, timing, and severity.
Treatment
What does that mean for your treatment
No SMARCA4-specific treatment or drug-selection approach is currently established in clinical guidelines. Cancers with loss of the SMARCA4 gene are being studied as a biomarker for some cancer treatments, including drugs that boost the immune system and newer targeted medicines.
Conditions associated with SMARCA4
Gene function
What if the gene works
Many everyday cell tasks depend on the SMARCA4 gene keeping DNA easy to reach. Its protein uses energy to shift how DNA is packed, so cells can read the right instructions at the right time. Understanding what the SMARCA4 gene does in your cells helps explain how growth, development, and routine cell upkeep stay organized.
The SMARCA4 gene helps loosen or reposition DNA packaging so important stretches of DNA can be reached. This lets cells read needed instructions without changing the DNA code itself.
By opening some DNA regions and closing others, this gene helps switch sets of genes on or off at the right time. That supports orderly cell activity, including growth, division, and normal responses to signals.
SMARCA4 supports the gene activity patterns that help cells take on specific jobs as the body develops. It also helps many mature cells keep their usual role over time.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMARCA4 gene can leave cells with too little working protein or with a protein that is made but works poorly. Some changes cut the protein short, while others alter key parts so it cannot use energy properly or interact normally with its partner complex, which helps explain how SMARCA4 variants affect gene function. Milder variants may leave partial activity, but more disruptive variants can greatly reduce or abolish activity and may be linked to earlier or more marked SMARCA4-related features.
How variants are linked to conditions
Pathogenic variants in the SMARCA4 gene are linked to several well-established conditions. Inherited SMARCA4 gene variants can cause Coffin-Siris syndrome and rhabdoid tumor predisposition syndrome, and they are also associated with a rare ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type. Variants found only in tumor cells, rather than inherited through a family, are also seen in some thoracic, lung, ovarian, and other cancers.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that increase or reduce health risks linked to the SMARCA4 gene. For many living with a harmful SMARCA4 change, risk is driven mainly by the variant itself, so care usually focuses on awareness, monitoring, and early detection.
Inheritance of SMARCA4 variants
SMARCA4-related conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the SMARCA4 gene can be enough to cause or increase the chance of a related condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In some families, a SMARCA4 variant is inherited across generations, while in other people it happens for the first time as a new, de novo variant. This is the key point in understanding how SMARCA4 variants are inherited.
What does my SMARCA4 result mean for my family?
For SMARCA4, family implications usually follow a dominant pattern, so close relatives such as parents, siblings, and children may also carry the same gene change. That can matter because SMARCA4 is linked to certain inherited cancer risks and, in some families, a developmental condition. Some SMARCA4 changes happen for the first time in one person, so a parent does not always carry it.
Genetic information
Genetic testing
How you find out about variants
SMARCA4 genetic testing usually uses a blood or saliva sample to look for variants in the SMARCA4 gene. A laboratory reads the DNA code and checks for changes linked to inherited cancer risk or found in a tumor, helping clarify whether a variant is present and whether family testing may be relevant.
When should I consider getting a genetic test?
Consider SMARCA4 testing if you or a close relative had a rare aggressive ovarian cancer linked to this gene, or if a child in the family had a rhabdoid tumor, a rare cancer that often starts in early childhood. Testing may also be part of an evaluation for some developmental conditions in children.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or react to a drug differently. These differences are common and help explain why medication response is often individual rather than the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how differences in genes affect the way people respond to medications. It looks at gene and drug patterns to understand why the same treatment can work differently from one person to another. For many medicines, genes influence how the body handles a drug and how strong its effects may be. This information can support more informed and individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SMARCA4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so general questions about symptoms, treatment side effects, or medicines are best discussed with your doctor. In cancer research, SMARCA4 changes are being studied because they may affect how some tumors respond to certain treatments, but this is not routine medication guidance for most people.
History
The SMARCA4 gene entered medical genetics through basic research on cell growth and cancer in the 1990s, when scientists identified it as the human version of an earlier gene studied in yeast. It was also known as BRG1 in many early papers, reflecting the naming used at the time. From these first observations, research expanded steadily. Over time, changes in the SMARCA4 gene were linked to several cancers, including uncommon ovarian tumors and rhabdoid tumors, which helped move it from laboratory science into clinical care. Its history became especially important when families with inherited SMARCA4 variants were recognized, showing that some cancer risk could run in families through this gene. That work helped establish SMARCA4 as a well-known cancer susceptibility gene in modern genetics.